GSK Pakistan Faces Legal Challenges Over Drug Quality

Karachi, GlaxoSmithKline Pakistan Limited (GSK) has announced that the Drug Court in Rawalpindi issued a judgment on April 22, 2024, against current and former officers of the company. The case, identified as Judicial No. 4229/DC/Rwp/22, addresses allegations of the provision of sub-standard drugs, as outlined in the Drugs Act of 1976.

GSK has rejected the accusations, stating that neither the company nor the implicated officers have committed any wrongdoing. The firm has also declared its intention to appeal the decision and will continue to update stakeholders on any significant developments related to this case.